Belperio John A, Keane Michael P, Burdick Marie D, Londhe Vedang, Xue Ying Ying, Li Kewang, Phillips Roderick J, Strieter Robert M
Department of Medicine, Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California 90024-1922, USA.
J Clin Invest. 2002 Dec;110(11):1703-16. doi: 10.1172/JCI15849.
Mortality related to adult respiratory distress syndrome (ARDS) ranges from 35% to 65%. Lung-protective ventilator strategies can reduce mortality during ARDS. The protective strategies limit tidal volumes and peak pressures while maximizing positive end-expiratory pressure. The efficacy of this approach is due to a reduction of shear-stress of the lung and release of inflammatory mediators. Ventilator-induced lung injury (VILI) is characterized by inflammation. The specific mechanism(s) that recruit leukocytes during VILI have not been elucidated. Because the murine CXC chemokines KC/CXCL1 and MIP-2/CXCL2/3, via CXCR2, are potent neutrophil chemoattractants, we investigated their role in a murine model of VILI. We compared two ventilator strategies in C57BL/6 mice: high peak pressure and high stretch (high peak pressure/stretch) versus low peak pressure/stretch for 6 hours. Lung injury and neutrophil sequestration from the high-peak pressure/stretch group were greater than those from the low-peak pressure/stretch group. In addition, lung expression of KC/CXCL1 and MIP-2/CXCL2/3 paralleled lung injury and neutrophil sequestration. Moreover, in vivo inhibition of CXCR2/CXC chemokine ligand interactions led to a marked reduction in neutrophil sequestration and lung injury. These findings were confirmed using CXCR2(-/-) mice. Together these experiments support the notion that increased expression of KC/CXCL1 and MIP-2/CXCL2/3 and their interaction with CXCR2 are important in the pathogeneses of VILI.
与成人呼吸窘迫综合征(ARDS)相关的死亡率在35%至65%之间。肺保护性通气策略可降低ARDS期间的死亡率。这些保护性策略限制潮气量和峰值压力,同时使呼气末正压最大化。这种方法的有效性源于肺剪切应力的降低和炎症介质的释放。呼吸机诱导的肺损伤(VILI)以炎症为特征。VILI期间募集白细胞的具体机制尚未阐明。由于小鼠CXC趋化因子KC/CXCL1和MIP-2/CXCL2/3通过CXCR2是有效的中性粒细胞趋化剂,我们在VILI小鼠模型中研究了它们的作用。我们在C57BL/6小鼠中比较了两种通气策略:高峰值压力和高牵张(高峰值压力/牵张)与低峰值压力/牵张,持续6小时。高峰值压力/牵张组的肺损伤和中性粒细胞滞留大于低峰值压力/牵张组。此外,KC/CXCL1和MIP-2/CXCL2/3的肺表达与肺损伤和中性粒细胞滞留平行。此外,体内抑制CXCR2/CXC趋化因子配体相互作用导致中性粒细胞滞留和肺损伤显著减少。使用CXCR2(-/-)小鼠证实了这些发现。这些实验共同支持了以下观点:KC/CXCL1和MIP-2/CXCL2/3的表达增加及其与CXCR2的相互作用在VILI的发病机制中很重要。